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Abstract. 
 
Thrombospondin (TSP) 2, and its close rela-
tive TSP1, are extracellular proteins whose functions 
are complex, poorly understood, and controversial. In 
an attempt to determine the function of TSP2, we dis-
rupted the 
 
Thbs2
 
 gene by homologous recombination 
in embryonic stem cells, and generated TSP2-null mice 
by blastocyst injection and appropriate breeding of mu-
tant animals. 
 
Thbs2
 
2
 
/
 
2
 
 mice were produced with the 
expected Mendelian frequency, appeared overtly nor-
mal, and were fertile. However, on closer examination, 
these mice displayed a wide variety of abnormalities. 
Collagen fiber patterns in skin were disordered, and ab-
normally large fibrils with irregular contours were ob-
served by electron microscopy in both skin and tendon. 
As a functional correlate of these findings, the skin was 
fragile and had reduced tensile strength, and the tail 
was unusually flexible. Mutant skin fibroblasts were de-
fective in attachment to a substratum. An increase in 
total density and in cortical thickness of long bones was 
documented by histology and quantitative computer to-
mography. Mutant mice also manifested an abnormal 
bleeding time, and histologic surveys of mouse tissues, 
stained with an antibody to von Willebrand factor, 
showed a significant increase in blood vessels. The basis 
for the unusual phenotype of the TSP2-null mouse 
could derive from the structural role that TSP2 might 
play in collagen fibrillogenesis in skin and tendon. 
However, it seems likely that some of the diverse mani-
festations of this genetic disorder result from the ability 
of TSP2 to modulate the cell surface properties of mes-
enchymal cells, and thus, to affect cell functions such as 
adhesion and migration.
 
T
 
hrombospondin 
 
(TSP)
 
1
 
 2 is a member of a family
of five, secreted, modular glycoproteins whose func-
tions in the extracellular matrix are diverse and
poorly understood (Frazier, 1991; Adams and Lawler,
1993; Bornstein and Sage, 1994; Bornstein, 1995). TSP1
and TSP2 are structurally more similar to each other than
to TSPs 3–5 and are, therefore, considered to constitute a
subfamily; the two proteins have an identical domain
structure and are secreted as disulfide-bonded homotri-
mers (Bornstein et al., 1991
 
b
 
; Bornstein, 1992; Laherty et
al., 1992; Bornstein and Sage, 1994). This similarity in
structure is reflected in the finding that both TSP1 and
TSP2 interact with a number of the same cell surface re-
ceptors, including heparan sulfate proteoglycans, low den-
sity lipoprotein-related receptor protein (LRP), and the
integrin 
 
a
 
v
 
b
 
3
 
 (Chen et al., 1994, 1996).
Despite the high degree of similarity in the coding re-
gions of 
 
Thbs2
 
 and 
 
Thbs1
 
, the DNA sequences of the two
promoters are very different. As a result, 
 
Thbs2
 
 does not
display the rapid transcriptional responses to growth fac-
tors, such as PDGF and basic FGF, and to serum, that
were observed for 
 
Thbs1
 
 (Bornstein et al., 1991
 
a
 
; Born-
stein, 1992). The two genes also respond differently to
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ACTH treatment in bovine adrenocortical cells (Lafeuil-
lade et al., 1996) and during osteoblast differentiation of
MC3T3-E1 cells (Sherbina and Bornstein, 1992). Finally,
the transcripts for each of the two genes display character-
istic spatial and temporal distribution patterns in the de-
veloping mouse embryo (Iruela-Arispe et al., 1993).
As is true for TSP1, the biological role of TSP2 remains
elusive. TSP2 mRNA, as detected by in situ hybridization
in mouse (Iruela-Arispe et al., 1993) and chick embryos
(Tucker, 1993), appears predominantly in connective tis-
sues such as dermis, tendon, ligament, perichondrium, and
pericardium; it is also present in smooth muscle and endo-
thelial cells. However, the function of TSP2 in these tis-
sues and cells, and elsewhere, remains unclear. It has been
shown that TSP2 inhibits the angiogenic activity of basic
FGF (Volpert et al., 1995) and the formation of focal ad-
hesions in bovine aortic endothelial cells (Murphy-Ullrich
et al., 1993). TSP2 is also capable of inhibiting the spread-
ing of bovine adrenocortical cells (Pellerin et al., 1994).
In an effort to understand the biological role of TSP2,
we disrupted the 
 
Thbs2
 
 gene in murine embryonic stem
cells and generated homozygous TSP2-null mice. 
 
Thbs2
 
 
 
2
 
/
 
2
 
mice, which lack normal TSP2 mRNA and protein, were
produced with the expected Mendelian frequency, were
normal in appearance, and reproduced normally. However,
these animals displayed structural and functional abnor-
malities in a variety of connective tissues, including skin,
tendon, bone, and blood vessels, and mutant skin fibro-
blasts were defective in attachment to a substratum. Inter-
estingly, collagen fibrils in both skin and tendon were ab-
normal in size and contour when viewed in the electron
microscope. These changes are reminiscent of the abnor-
malities in collagen fibril structure seen in the human ge-
netic disorder, Ehlers-Danlos syndrome (EDS) I (Vogel et
al., 1979), in which mutations in the fibril-associated type
V collagen have been found (Burrows et al., 1996), and in
EDS IV, which results from defects in type III collagen
(Byers, 1995; Smith et al., 1997). Targeted disruptions of
types V and III collagens in mice produce more severe
versions of these phenotypes (Andrikopoulos et al., 1995;
Liu et al., 1997). Abnormal collagen fibrils are also seen in
EDS VII, which can result either from mutations in type I
collagen chains that hinder the action of procollagen
 
N
 
-proteinase, or from defects in the proteinase itself (By-
ers, 1995). Recently, targeted disruption of the collagen
fibril-associated proteoglycan, decorin, which is known to
modulate fibril size (Iozzo and Murdoch, 1996), generated
mice with fragile skin and collagen fibrils of abnormal size
and shape (Danielson et al., 1997).
TSP1 has been shown to bind to a number of collagens;
highest affinity binding was seen with type V collagen and
was sensitive to calcium ion concentration (Mumby et al.,
1984; Galvin et al., 1987). On the other hand, collagen-
binding studies have not been reported for TSP2 and nei-
ther protein is known to serve as an integral structural
component of collagen fibrils. Similarly, the abnormality
in bone and the bleeding defect observed in mice lacking
TSP2 were unexpected. The findings in TSP2-null mice,
therefore, raise a number of fundamental questions relat-
ing to cell–matrix interactions, collagen fibrillogenesis, and
matrix assembly, questions that we have answered in part
by an investigation of the mice described in this report.
 
Materials and Methods
 
Construction of Targeting Vector, Homologous 
Recombination in Embryonic Stem (ES) Cells, and 
Generation of Mutant Mice
 
A 129 mouse genomic 
 
l
 
 phage library was screened with a 444-bp frag-
ment from the 5
 
9
 
 end of mouse 
 
Thbs2
 
 cDNA, and several positive phage
were identified and plaque-purified. A 13-kb genomic fragment, extend-
ing from intron I to intron IX, was cloned in pGEM5. This fragment was
modified in successive steps to yield a 4.8-kb genomic fragment containing
1.5 kb of sequence 5
 
9
 
 and 3.3 kb of sequence 3
 
9
 
 to a deletion of 
 
z
 
2.6 kb.
The deleted segment included exon 2, which contains the translation start
site, and exon 3 of the gene. A 
 
PGK-Neo
 
 cassette was then inserted at the
site of the deletion. Finally, a 
 
PGK-TK
 
 cassette was cloned 5
 
9
 
 to the 1.5-kb
genomic sequence to yield the targeting vector (see Fig. 1 
 
A
 
).
J1 ES cells (129/SvJ; a gift of R. Jaenisch, Massachusetts Institute of
Technology, Boston, MA) and RW4 ES cells (129/SvJ; Genome Systems,
St. Louis, MO) were cultured on neomycin-resistant fibroblasts in DME
(high glucose) supplemented with 15% fetal calf serum (ES-qualified;
GIBCO BRL, Gaithersburg, MD), 0.1 mM 
 
b
 
-mercaptoethanol, 2 mM
L-glutamine, 100 U/ml penicillin G, 100 
 
m
 
g/ml streptomycin, and 1,000 U/ml
of leukemia inhibitory factor (GIBCO BRL). Cells (10
 
7
 
) were electropo-
rated with 30 
 
m
 
g of TSP2 targeting vector that was linearized with KpnI.
Selection with G418 and gancyclovir was started 24 and 72 h after elec-
troporation, respectively, and resistant clones were picked typically 9–10 d
later. DNA was extracted from expanded clones as described by Laird et
al. (1991), digested with BamHI, and analyzed by Southern blotting. The
genomic probe encompassed 500 bp of DNA 5
 
9
 
 to the 
 
Thbs2
 
 sequence
present in the targeting vector and detected a 6- or 4.8-kb BamHI frag-
ment, derived from a wild-type or a targeted allele, respectively (see Fig. 1 
 
A
 
).
Correctly targeted ES cells were microinjected into C57BL/6 mouse
blastocysts and the resulting male chimeras were mated with C57BL/6 fe-
males. Agouti progeny were genotyped by Southern blot analysis of tail
DNA. Heterozygous offspring were then bred to homozygosity. Subse-
quently, chimeras derived from both J1 and RW4 ES cells were mated
with 129/SvJ females, and germline heterozygous animals were mated to
produce homozygous TSP2-null mice in a homogeneous 129 background.
 
RNA and Protein Extraction: Northern and
Western Blots
 
Extraction of RNA from 18-d-old embryos and fibroblasts was carried out
by the guanidinium thiocyanate method (Chomczynski et al., 1987). RNA
was separated on 1% agarose gels containing 2.2 M formaldehyde. For
Western blots, protein was extracted from 18-d-old embryos after removal
of the head and viscera. Tissues were homogenized in a Dounce glass ho-
mogenizer in cold extraction buffer (1% NP-40, 150 mM NaCl, 50 mM
Tris-HCl, pH 8.0, 3 mM CaCl
 
2
 
, 100 
 
m
 
g/ml phenylmethylsulfonyl fluoride,
1 
 
m
 
g/ml pepstatin A, and 0.5 
 
m
 
g/ml leupeptin). The resulting homogenate
was centrifuged at 3,000 rpm for 5 min at room temperature and heated at
95
 
8
 
C for 5 min. Protein concentration was assayed by absorbance at 595 nm
with a protein assay reagent (Bio-Rad Laboratories, Cambridge, MA),
and equal amounts of protein were separated on a 7% polyacrylamide gel.
After transfer to Zetabind membrane (Cuno Inc., Meriden, CT) for 1 h at
100 V, the membrane was air-dried for 30 min in the dark and blocked for
1 h with 5% nonfat milk in PBS plus 0.3% Tween-20. The membrane was
then incubated in PBS with anti–mouse TSP2 antibody. Two antibodies
produced similar results; one was generated in a guinea pig against the
amino-terminal region of mouse TSP2, (amino acids 1–296, including the
heparin-binding domain), and the other (a kind gift of D. Mosher, Univer-
sity of Wisconsin, Madison, WI), in rabbits against intact TSP2. Both anti-
gens were generated in a baculovirus expression system. The membrane
was washed further with PBS and then incubated with an anti–rabbit or
anti–guinea pig IgG–biotin conjugate. The resulting antigen–antibody com-
plexes were detected by incubation in A and B reagent (BioRad Labora-
tories, Hercules, CA).
 
Tissue Sampling, Histology, Immunolocalization, and 
Electron Microscopy
 
Soft tissues were dissected, fixed in 10% buffered formalin, and processed
for histological examination by light microscopy. The femurs and tibias 
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were excised, dissected to the periosteum, and fixed in 70% ethanol. The
right femurs and tibias were then reserved for bone density determina-
tions, whereas the bones in the left leg were fixed afterwards in phos-
phate-buffered formalin and were processed for histology. After formalin
fixation, the diaphyseal samples of long bones were demineralized in buff-
ered formic acid (equal proportions of 5% formic acid and 20% sodium ci-
trate, pH 4.2), washed, partially dehydrated in 70% ethanol, and embed-
ded in paraffin. 4 
 
m
 
m sections were cut with a Reichert Jung rotary
microtome, mounted on glass slides, and stained with hematoxylin and
eosin (H & E). Soft tissue sections were stained with Verhoeff-van Gieson,
orcein, or H & E stains, according to standard procedures.
For immunolocalization of TSP2, paraffin sections of skin from the
back of 3-mo-old mice were heated at 60
 
8
 
C for 15 min, dewaxed in xylene,
and rehydrated through a graded series of ethanol. Subsequently, the sec-
tions were treated with 3% H
 
2
 
O
 
2
 
, 0.1% sodium azide in methanol,
blocked with 1% BSA in PBS, and then incubated with anti-TSP2 anti-
body at a 1:1,000 dilution. Detection of TSP2-specific immunoreactivity
was achieved with an Elite ABC kit (Vector Labs, Inc., Burlingame, CA),
according to the suppliers instructions. After development of peroxidase
activity, sections were counterstained with methyl green for 30 s, dehy-
drated through a graded series of ethanol, mounted with Cytoseal 60
(Stephens Scientific, Riverdale, NJ), and examined with the aid of a Ni-
kon Eclipse 800 microscope.
For immunolocalization of von Willebrand factor (vWF), paraffin sec-
tions were dewaxed and rehydrated as described above, and then treated
with 0.2% Tween-20 in PBS for 30 min, followed by treatment with a 1:1
solution of 0.25% trypsin (GIBCO BRL) and 0.025% pronase (Sigma
Chemical Co., St. Louis, MO; P-8038) for 10 min at 37
 
8
 
C. The sections
were then blocked with 10% goat serum at 4
 
8
 
C overnight. After incuba-
tion in anti-vWF antibody (Dako Corp., Carpinteria, CA) at 1:500 dilu-
tion, the sections were incubated sequentially in anti–rabbit biotin-conju-
gated antibodies, 3% hydrogen peroxide/0.15% sodium azide/0.05%
Tween-20 in PBS, avidin-biotin-peroxidase reagent, and diamino-benzidine
substrate (Vector Labs, Inc.), with PBS washes (two washes for 5 min
each) between each step. After visualization of the specific peroxidase ac-
tivity, the sections were counterstained in Gill’s No. 2 hematoxylin, and
dehydrated and mounted as described above.
All sections stained with anti-vWF antibodies were number coded to
allow investigators to perform blind analyses. For transverse sections of
embryos, sections were chosen from the same areas of the embryo, as indi-
cated by the appearance of tissues such as thymus, the arch of the aorta,
and the limbs. For neonatal and adult tissues, the skin sections were cho-
sen from the lower back of the mouse and, after processing, were embed-
ded and sectioned in a consistent orientation. For analysis, the number of
vessels were scored with the aid of a Nikon Eclipse 800 microscope using
the 40
 
3
 
 objective and the photographic eyepiece. The visible area was
calculated to be 0.075 mm
 
2
 
 with the aid of a 2-mm graded guide. Each
sample was scored twice; depending on the size and number of available
sections, 7–20 0.075 mm
 
2
 
 areas were scored per sample.
Samples of skin, including the panniculus carnosus, were removed from
the back and shoulder regions, and fixed in 0.1 M sodium cacodylate
buffer containing 2.5% glutaraldehyde and 2% paraformaldehyde. The
tissue was processed for electron microscopy as previously described
(Smith et al., 1997). The magnification of electron micrographs was cali-
brated with a carbon replica containing 2,160 lines per mm (Ernest F. Ful-
lam, Latham, NY). Electron micrographs of collagen fibril cross-sections
were taken at 30,000
 
3
 
 magnification. Micrographs were digitized at 72 dpi
using an Epson 1200 scanner with Adobe Photoshop 3.0 and Scantastics.
The images were transferred into NIH image version 1.52, treated by
thresholding, binarized, and analyzed for fibril area and perimeter length.
The data were transferred to Excel, and fibril diameters were calculated
using 2
 
Î
 
 (area/
 
p
 
). To determine the diameters of skin collagen fibrils, mi-
crographs were taken from the skin of several 
 
Thbs2
 
2
 
/
 
2
 
 and 
 
Thbs2
 
1
 
/
 
1
 
animals at 30,000
 
3
 
 magnification. A total of 1,090 collagen fibrils were
measured using NIH Image software, and histograms were generated.
 
Measurements by Peripheral Quantitative Computer 
Tomography (pQCT)
 
To evaluate bone density changes, pQCT scans using a Norland/Stratec
XCT 960M instrument were performed at the distal femur and at the mid-
shafts of the femur and tibia. The total bone density and trabecular density
(mg/cm
 
3
 
) at each site were determined from transverse scans of 0.5 mm
thickness. In addition, midshaft cortical thicknesses were calculated from
computer-generated algorithms based on cross-sectional geometries. The
measurement site for the distal femur was taken as a point halfway be-
tween the distal condyle and the midshaft of the diaphysis. The midshaft
was the midpoint on the diaphysis. In both instances, the sampling sites
were established from bone length measurements determined from pQCT
scout views of individual samples.
 
Analysis of Skin Tensile Strength
 
The tensile strength of skin from 
 
Thbs2
 
 
 
1
 
/
 
1
 
, 
 
Thbs2
 
 
 
2
 
/
 
2
 
, and decorin 
 
2
 
/
 
2
 
mice (which served as a positive control) was analyzed as previously de-
scribed (Danielson et al., 1997), with the following modifications. Tensile
strength measurements of dorsal skin samples were performed with a
tabletop tensile-testing machine (Model T-5000; Satec Systems, Inc.,
Grove City, PA). To avoid slippage, the samples were gripped between
clamps equipped with adhesive lycra-covered pads. Skin specimens were
stretched at a constant speed of 10 mm/min until failure.
 
Skin Fibroblasts: Isolation, Culture, and
Attachment Assays
 
Skin fibroblasts were isolated by explant culture of biopsies taken from
the backs of adult or neonatal mice. Specimens were cut into 1 mm
 
2
 
 frag-
ments and allowed to adhere to the surface of 35 mm plates for 5 min.
DME, supplemented with 10% fetal calf serum, 2 mM L-glutamine, 100 U/ml
penicillin G, 100 
 
m
 
g/ml streptomycin, and 0.25 
 
m
 
g/ml fungizone, was
added to dishes, and the medium was changed periodically until the ex-
plant-derived cells had become confluent. After two subcultures, the cell
population appeared, morphologically, to be composed entirely of fibro-
blasts.
Attachment assays were performed by modifications of the method of
Aumailley et al. (1989). Confluent skin fibroblasts in culture were tryp-
sinized and resuspended in DME containing 10% fetal bovine serum. The
cell suspension was adjusted to a final concentration of 2 
 
3
 
 10
 
5
 
 cells/ml,
100 
 
m
 
l of each cell type was plated in four wells of a 96-well tissue culture
plate, and the plates were incubated at 37
 
8
 
C for 60 min. Wells were either
untreated or coated overnight at 4
 
8
 
C with 100 
 
m
 
l/well of TSP2, vitronectin,
or fibronectin, each at 5 
 
m
 
g/ml in PBS. Type I collagen was coated in 0.01
N HCl. In addition, a separate aliquot of cells was plated in 60 mm dishes
and, after a 60-min incubation at 37
 
8
 
C, the unattached cells, 
 
z
 
50 % of the
number plated, were collected and used in the same attachment assay in
separate 96-well tissue culture plates. Unattached cells in the 96-well tis-
sue culture plates were removed by washing the plates with DME. At-
tached cells were fixed with 10% formalin in saline for 30 min and were
stained for 30 min with 50 
 
m
 
l/well of 1% methylene blue in 100 mM Tris-
HCl buffer, pH 8.0. The plates were then destained for 15 min. After air-
drying, the methylene blue that had adsorbed onto the attached cells was
solubilized with 0.2% Triton X-100 (50 
 
m
 
l/well). Color yields were mea-
sured at 650 nm in a microplate reader. Linearity between optical density
and the number of cells attached to a plate was demonstrated by a propor-
tional increase in optical density over an eightfold range in cell concentra-
tion.
 
Determination of Bleeding Time
 
3-mo-old male mice were used to determine bleeding times. Mice were re-
strained in a 50-ml falcon tube with holes in its tip and cap. The tail was
passed through the cap and a 1-cm segment from the tip of the tail was ex-
cised with a sharp razor blade. The tail was kept at the level of the heart
during the experiment. Bleeding was monitored by gently absorbing the
bead of blood on the tail with a Kimwipe, with care taken not to allow
contact with the wound site. Cessation of bleeding was determined by an
investigator with no knowledge of the mouse genotype, and was scored to
the nearest 0.5 min interval. All experiments were performed at room
temperature.
 
Results
 
Generation of TSP2-null Mice, Initial Characterization, 
and Phenotype
 
To disrupt the TSP2 gene by homologous recombination,
J1 and RW4 ES cell lines were electroporated with a tar-
geting construct (Fig. 1 
 
A
 
), and selected in G418 and gan- 
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cyclovir. Surviving cell colonies were screened by Southern
blotting (Fig. 1 
 
B
 
). A frequency of homologous recombi-
nation of 10 and 2%, respectively, was observed with the
two cell lines. Correctly targeted clones were subsequently
screened by Southern blotting with a probe specific for the
 
PGK-Neo
 
 cassette to exclude the possibility of an addi-
tional nonhomologous recombination event (data not
shown).
Cells from several correctly targeted ES cell clones were
injected into C57BL/6 blastocysts that were subsequently
introduced into pseudopregnant foster mothers. Several
male chimeras transmitted the disrupted TSP2 allele through
the germline. For this study we used a chimera with a 50%
degree of chimerism by coat color, derived from a J1 cell
clone, and a 95% chimera from an RW4 cell clone. The J1-
derived chimera was initially bred with C57BL/6 females;
subsequently, both chimeras were bred with 129/SvJ fe-
males to achieve a homogeneous 129 background for the
mutation.
When a total of 160 offspring of heterozygous 
 
Thbs2
 
 
 
1
 
/
 
2
 
matings were genotyped by Southern blotting (Fig. 1 
 
C
 
),
the expected Mendelian ratio of 39 
 
1
 
/
 
1
 
, 82 
 
1
 
/
 
2
 
, and 39
 
2
 
/
 
2
 
 animals was observed. Thus, TSP2 is not essential for
blastocyst implantation or embryonic development. 
 
Thbs2
 
2
 
/
 
2
 
 mice appeared normal on superficial examination
and were able to reproduce normally. A higher incidence
of sporadic deaths of adult animals within the TSP2-null
population has been observed, but a specific cause of
death of these animals has not been determined. As mu-
tant mice aged, a proportion developed a mild kyphosis
which appeared to result from lax ligaments rather than
from a bony abnormality. The absence of TSP2 mRNA
and of immunoreactive protein in 
 
Thbs2
 
 
 
2
 
/
 
2
 
 mice was
demonstrated by Northern blot and immunoblot analyses,
respectively, of embryonic tissue (Fig.1, 
 
D
 
 and 
 
E
 
). The ab-
sence of full-length 
 
Thbs2 mRNA was also shown by re-
verse transcriptase-PCR assays with primers specific for
sequences 59 and 39 to the PGK-Neo insert (data not
shown), and immunohistochemical analysis of both em-
bryonic and adult tissues with anti-TSP2 antibodies con-
firmed the lack of TSP2 protein (see below). However, on
overexposure of Northern blots of RNA from neonatal
and embryonic mutant fibroblasts, a band of z5.3 kb was
observed. The size of this band is consistent with the possi-
bility that the neomycin cassette was spliced out, yielding
an mRNA that lacks exon 2, with its translation start site,
Figure 1. Disruption of the Thbs2 gene and
characterization of TSP2-null mice. (A) Tar-
geting strategy. A schematic representation
of the Thbs2 gene locus is shown on the first
line. The targeting construct consists of a
PGK-TK cassette, and 1.5 and 3.3 kb of ge-
nomic sequence (dotted vertical lines) flank-
ing a PGK-Neo cassette. The directions of
transcription of the TK and Neo genes are in-
dicated by the bold arrows. In the targeted al-
lele, the PGK-Neo cassette replaces 2.6 kb of
genomic DNA, which contains exons 2 and 3
of the gene. Angled arrows indicate the start
of transcription of Thbs2, and open and filled
boxes represent untranslated and translated
exons, respectively. B, BamHI; E, EcoRI; K,
KpnI. (B) Southern analysis of BamHI di-
gests of DNA from electroporated ES clones.
The probe (A, top) detects a 6-kb fragment in
a digest of a wild-type clone (lane 1), and
bands of 6 kb and 4.8 kb in a digest of a tar-
geted clone (lane 2). (C) Southern analysis of
tail DNA from the progeny of Thbs2 1/2
mice, analyzed as in B. The pattern of 6.0-
and 4.8-kb bands indicates that the animals
analyzed in lanes 1 and 2 are Thbs2 1/2, that
in lane 3 is Thbs2 1/1, and that in lane 4 is
Thbs2 2/2. (D) Northern blot analysis of
RNA prepared from cultured embryonic fi-
broblasts. Hybridization was performed with
a 32P-labeled 515-bp Thbs2 cDNA probe (nu-
cleotides 834–1,348), or with a b-actin cDNA
probe. Lanes 1 and 2 were loaded with 5 and
10 mg of fibroblast RNA, respectively, derived from a Thbs2 2/2 embryo. Lanes 3 and 4 were loaded with 5 and 10 mg, respectively, of
fibroblast RNA derived from a Thbs2 1/1 embryo. The faster migrating transcript has been observed by us and others in the past; its
nature is unknown. (E) Immunoblot analysis of protein (50 mg) extracted from 17-d-old embryos. An anti-TSP2 antibody was used.
Lane 1, protein from a Thbs2 1/1 embryo. A band migrating at the expected molecular mass 200 kD is observed. A faster migrating
band is also present and is likely to represent a proteolytic fragment of TSP2 since its presence and intensity were variable. Lane 2, pro-
tein from a Thbs2 2/2 embryo. The same samples were immunoblotted with anti-TSP1 antibodies and the presence of approximately
equal levels of a TSP1-specific band was evident in both samples (data not shown).Kyriakides et al. Thrombospondin 2 Knockout Mice 423
and exon 3. This possibility was supported by the results of
reverse transcriptase-PCR on this RNA (results not shown).
However, this aberrant minor mRNA species is appar-
ently not translated from a downstream ATG in the TSP2
reading frame. To determine whether TSP2-null mice up-
regulated the expression of the closely related Thbs1 gene,
Northern analyses of RNA extracted from 17-d-old em-
bryos and from neonatal skin fibroblasts were performed.
Little or no compensatory increase in expression of Thbs1
was observed in either case (data not shown).
The phenotype of TSP2-null adult mice derived from the
J1 clone, in a mixed 129/SvJ and C57BL/6 background, is
characterized by moderate skin fragility, lax tendons and
ligaments, an increase in bone density, an increased den-
sity of medium and small blood vessels, and a bleeding di-
athesis. Light and electron microscopy of skin, and elec-
tron microscopy of tendon indicated abnormalities in
collagen fibers and fibrils. Histology and computerized to-
mography documented the increase in bone density. Some
features of this phenotype are shown in Figs. 2 and 3. Pre-
liminary examination of mutant mice derived from the
RW4 ES cell clone, in a pure 129 background, has identi-
fied no discrepancies and confirmed several features of
this phenotype, including abnormal dermal collagen fibrils,
increased vascularity of the dermis and subdermal adipose
tissue, and increased bleeding time.
TSP2-null Mice Exhibit a Striking Abnormality in Skin
Although the skin coat and nails of TSP2-null mice ap-
peared normal, an increase in skin laxity and fragility was
occasionally noted during handling of the mice. These
findings were supported by an increased incidence of su-
perficial lacerations in the mutant colony, presumably re-
sulting from fighting. To determine whether an anatomical
basis existed for the increased fragility, skin was sampled
from the back, flank, and leg of TSP2-null and wild-type
mice, and was examined by light microscopy. A disorga-
nized collagen fiber weave and an abnormal packing of
Figure 2. Appearance of the TSP2-null mouse. Disruption of the
Thbs2 gene does not alter the gross appearance of the mouse, but
the increased flexibility of tail tendons and ligaments permits the
tying of a knot in the tail. This manipulation is not possible in a
normal mouse.
Figure 3. Histological analy-
sis of skin and bone in the
TSP2-null mouse. (A and B)
Dermis from the back of a
Thbs2 1/1 mouse (A) and a
Thbs2  2/2 mouse (B),
stained with Verhoeff-van
Gieson stain. Collagen fibers
stain orange-red and epider-
mis, cells, and hair follicle
stain yellow-brown. The
collagen fibers in A form
a wicker-like mesh but are
largely oriented parallel to
the epidermal surface. Col-
lagen fibers in B appear dis-
organized and lack the pre-
dominant orientation parallel
to the epidermal surface.
Bar, 50 mm. (C and D) Mid-
diaphyseal cross-section of the
femur of a Thbs2 1/1 mouse
(C) and a Thbs2 2/2 mouse
(D), stained with H & E. The
increased cortical thickness
and reduced marrow cavity
of the femur from the mutant
animal are evident. The less
regularly oval contour, and
tendency to form a ridge, is
a feature of the abnormal
bone. Bar, 500 mm.The Journal of Cell Biology, Volume 140, 1998 424
collagen fibers were evident in mutant tissue. Whereas
skin from Thbs2 1/1 mice had a regular network of col-
lagen fibers that appeared relatively tightly packed and
was predominantly oriented parallel to the surface (Fig. 3
A), collagen fibers in Thbs2 2/2 tissue were disorganized,
more widely spaced, and lacked an orientation to the epi-
dermis (Fig. 3 B). However, the abnormality in dermal col-
lagen fibers was patchy and some areas appeared rela-
tively normal (data not shown). Immunohistochemical
analyses of skin demonstrated the presence of TSP2 in
dermal cells of Thbs2 1/1 mice, and its absence from the
cells of knockout animals (Fig. 4), but it was not possible
to determine, unequivocally, whether TSP2 was located in
collagen fibers of control animals, or whether the small
amount of reaction product in the control tissue that was
apparently fiber associated was present in cellular pro-
cesses or in the pericellular environment.
Electron microscopic examination of dermal collagen
from the skin of Thbs2 2/2 mice revealed the presence of
numerous fibrils that had uneven contours and were larger
than normal (Fig. 5 B). The presence of these abnormal
fibrils was limited largely to the reticular dermis and, as
was seen by light microscopy, regions of abnormality were
interspersed with more normal-appearing fibrils. In con-
trast, collagen fibrils in Thbs2 1/1 mice were more uni-
form in size and had relatively even contours (Fig. 5 A).
Cross-sectional profiles of collagen fibrils from areas se-
lected as abnormal were analyzed morphometrically. The
results showed an average diameter of 145 6 51 nm for the
fibrils of Thbs2 2/2 mice, which is significantly greater
(P < 0.001) than the average fibril diameter of 122 6 23
nm in Thbs2 1/1 mice (Fig. 6). It is of interest that find-
ings intermediate between those in wild-type and mutant
animals were observed in skin from heterozygous Thbs2
1/2 mice. Large fibrils were more numerous than in con-
trol tissue, but the contours of these fibrils were less irreg-
ular than those in TSP2-null animals (data not shown).
Thus, at least in skin, there is haplo-insufficiency for the
function of TSP2.
The impression of increased skin fragility in Thbs2 2/2
mice was confirmed by measurements of tensile strength.
Fig. 7, A and B, show stress/displacement curves of skin
obtained from the backs of Thbs2 1/1 and Thbs2 2/2
mice. Identical portions of skin removed from decorin-null
animals, known to exhibit a marked reduction in tensile
strength, were studied concurrently as positive controls.
The two panels describe curves obtained with specimens
from different animals. In both experiments the curves for
Thbs2 2/2 skin differed from those for Thbs2 1/1 con-
trol samples in that (a) the break point of the mutant tis-
sue was lower than that of the control (8 vs. 19 newtons in
A; 9 vs. 13 newtons in B); (b) the ascending slopes of the
curves for the Thbs2 2/2 tissue were less steep than those
for the control tissue, indicative of greater displacement
per unit increase in load, or increased elasticity (decreased
elastic modulus) of the pathological material; (c) the break
point of the Thbs2 2/2 samples occurred at a greater dis-
placement than that of the normal controls and the curves
showed a short plateau region, just before the break point,
during which increasing displacement occurred without an
increase in load. Both of these features are indicative of in-
creased ductility. Altogether, duplicate skin strips from
five Thbs2 2/2 and five Thbs2 1/1 mice were tested.
There was considerable variation in the load or force re-
quired to rupture the tissue, which is inherent in the
method, and several analyses were excluded for technical
reasons.On average, the mean point of failure for the two
tissues was significantly different (Thbs2 1/1: 11.9 6 1.55
Figure 4. Immunohistochemical analysis for TSP-2 in back skin
from (A) a Thbs21/1 mouse and (B) a Thbs2 2/2 mouse. The
sections were counterstained with methyl green. The presence of
TSP2 immunoreactivity, observed as brown-black color, is evi-
dent in A. The arrows indicate dermal cells that appear to be pos-
itive for TSP2. Immunoreactivity to the epidermis, sweat glands,
and hair follicles is, in part, nonspecific. Bar, 50 mm.
Figure 5. Electron micrographs of collagen fibrils in reticular
dermis from a Thbs2 1/1 mouse (A) and a Thbs2 2/2 mouse
(B). The presence of larger fibrils with irregular contours in the
tissue from the mutant animal, in comparison with the more uni-
formly sized circular fibrils in the control tissue, is evident. Bar,
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N (SEM), n 5 7; Thbs2 2/2: 8.7 6 0.37 N (SEM), n 5 10;
P < 0.07).
Tails and Tail Tendons Are Abnormal in
TSP2-null Mice
On close examination, Thbs2 2/2 mice were observed to
drag their tails while scampering, indicating poor control
of tail movement. The tail itself was highly flexible and
contained a series of subtle bends, even in its resting state.
The end of a mutant tail could be tied in a knot that was
often maintained for some minutes (Fig. 2). This manipu-
lation, which did not appear to distress the mouse, was im-
possible in the normal animal. When held by the tips of
their tails, TSP2-null mice also had considerable difficulty
in pulling their bodies up to the base of their tails, and the
arcs of the stressed tails tended to be abnormal when com-
pared to those of Thbs2 1/1 mice. Thus, it would appear
that the mice had abnormalities in tail tendons and in in-
tervertebral ligaments.
Although light microscopic analysis of sagittal and
cross-sections of tail tissue from Thbs2 2/2 mice did not
show consistent abnormalities, examination of tail tendon
from these mice by electron microscopy revealed the pres-
ence of abnormal collagen fibrils with greater than normal
diameters and uneven contours (Fig. 8 B). Thus, in con-
trast to the diameters of large control tendon fibrils that
were in the range of 250 nm (Fig. 8 A), the diameters of the
largest fibrils in Thbs2 2/2 tendon were as high as 400 nm.
Although we have not yet had the opportunity to examine
ligaments in tail tissue in detail, the impression of in-
creased laxity is supported by manual manipulation of
skeletal preparations.
TSP2-null Skin Fibroblasts Do Not Adhere Normally to 
a Substratum
Skin fibroblasts were isolated from neonatal (1-d-old) and
adult (3-mo-old) mice by explant culture of skin biopsies.
The growth rates of cells derived from Thbs2 1/1 and
Thbs2 2/2 mice were approximately equal, and analysis
of collagen synthesis revealed no significant differences
between normal and mutant cells, as determined by SDS-
PAGE of 3H-labeled proteins in culture medium, before
and after collagenase digestion (data not shown). How-
ever, the two cell populations differed in other growth
characteristics and in adhesive properties. Thbs2 2/2 cells
were less contact inhibited and assumed a multi-layered
arrangement at confluence. In addition, adherent Thbs2
2/2 cells were more sensitive to trypsinization from tissue
culture plastic, and their behavior differed from wild-type
cells when plated on surfaces such as glass or bacteriologi-
cal plastic. In contrast to Thbs2 1/1 cells that remained
dispersed as single cells or small clumps of cells after plat-
ing on bacteriological plastic (Fig. 9 A), aggregates of
Thbs2  2/2 cells were observed within an hour (Fig. 9 B),
and these aggregates grew in size with time, sometimes co-
alescing into a cell sheet. On tissue culture plastic, attach-
Figure 6. Distribution of collagen fibril diameters, as measured
from electron micrographs of skin from Thbs2 1/1 (solid bars)
and Thbs2 2/2 (shaded bars) mice. The distribution is skewed in
the direction of larger fibrils in the mutant tissue.
Figure 7. Measurements of tensile strength of skin from Thbs2
1/1, Thbs2 2/2, and decorin (Dcn) 2/2 mice. Force or load in
newtons is plotted against displacement or elongation of skin in
cm. A and B show experiments with tissues from different ani-
mals. In both, skin from TSP2-null mice ruptures at a lower load,
and shows increased ductility (greater displacement per unit in-
crease in load), than skin from control mice.
Figure 8. Electron micrographs of collagen fibrils in tendon from
(A) a Thbs2 1/1 mouse, and (B) a Thbs2 2/2 mouse. In B,
larger fibrils are relatively more numerous than smaller fibrils
and frequently display irregular contours. Small diameter fibrils
in A represent tapered fibril ends and are much less frequent in
B. Bar, 250 nm.The Journal of Cell Biology, Volume 140, 1998 426
ment of adult TSP2-null cells was reduced compared to
normal cells (Fig. 10 A), and this difference was more ap-
parent when cells that did not initially attach (z50%)
were replated on the same substratum (Fig. 10 B). Coating
of the surface with vitronectin or fibronectin did not cor-
rect the attachment defect (Fig. 10 B), nor did coating with
TSP2 or type I collagen (not shown). We conclude that the
defect in attachment of TSP2-null cells does not result from
a lack of attachment factors or TSP2, but from changes in
cell surface properties, possibly in adhesion receptors (see
Discussion).
TSP2-null Mice Display Increased Cortical Bone 
Thickness and Density
The possibility of an abnormality in bone in TSP2-null
mice was suggested by the distribution of TSP2 mRNA
(Iruela-Arispe et al., 1993) and protein (Kyriakides, T.R.,
Y.-H. Zhu, and P. Bornstein, manuscript in preparation)
at sites of chondrogenesis and osteogenesis during normal
embryonic development. Examination of tibias and fe-
murs from 3- and 5-mo-old mice by histology and pQCT
revealed increased total bone density and cortical thick-
ness. The mid-diaphyseal cross-sections of the 3-mo-old
femurs shown in Fig. 3, C and D, are indicative of the in-
crease in cortical bone thickness in the mutant mice. Five
control and TSP2-null mice were analyzed by pQCT and
the results of the tibial and femoral measurements are
summarized in Table I. Although there is variation among
normal animals and, as for skin and tendon, the mutant
phenotype appears to be incompletely penetrant, the dif-
ferences in total bone density and cortical thickness are
statistically significant.
Other Abnormalities in TSP2-null Mice
TSP2-null mice display at least two other abnormalities.
Mutant mice have an abnormally long bleeding time, as
judged by the length of time it takes for a tail wound to
stop bleeding. Mice were restrained in a simple device and
a 1-cm segment of tail was cut from the tip. The average
time for spontaneous cessation of bleeding in normal mice
was 2.2 min (n 5 5). Of the five TSP2-null mice, three con-
tinued to bleed beyond 10 min and required intervention.
The other two mice had bleeding times of 7.5 and 8.5 min.
Clotting parameters were normal in mutant mice. Specifi-
cally, the prothrombin and partial thromboplastin times
were 11.5 and 38 s, respectively, for Thbs2 2/2 mice (n 5
5), and 11.9 and 46 s, respectively, for Thbs2 1/1 mice (n 5
2). The platelet count of TSP2-null mice was 7.46 3 105/ml 6
5.8 3 104 (SD), n 5 5, which is significantly higher than
that in wild-type animals (5.99 3 105/ml 6 6.47 x 104 (SD),
n 5 5; P < 0.005).
TSP2-null mice also have a striking increase in the den-
sity of small- and medium-sized blood vessels in many tis-
sues. This characteristic was noticed first as an increase in
erythrocyte-containing structures in H & E- and Verhoeff-
van Gieson–stained sections of skin. Sections of adult,
Figure 9. Appearance of neonatal skin fibroblasts isolated from
Thbs2 1/1 mice (A) and Thbs2 2/2 mice (B) 1 h after plating on
bacteriologic plastic in DME. Control fibroblasts remain dis-
persed whereas fibroblasts from mutant mice form small aggre-
gates that coalesce with time. Bar, 50 mm.
Figure 10. Fibroblast attach-
ment assays. (A) Adult skin
fibroblasts (2 3 105/ml) were
plated, in the presence of
DME plus 10% serum, on
untreated (control) wells or
on wells coated with vit-
ronectin or fibronectin in a
96-well tissue culture plate,
and allowed to attach for 1 h.
Attached cells were quanti-
tated spectrophotometrically
by adsorbed methylene blue.
(B) In a separate experiment,
cells that did not attach un-
der conditions such as those
described in A were retested
for their ability to attach un-
der the same conditions.
Shaded bars, Thbs2 1/1
cells; open bars, Thbs2 2/2
cells. All differences are sig-
nificant (P < 0.05).
Table I. Quantification of Total Bone Density and Cortical 
Thickness in TSP2-null and Wild-type Mice
Femur Tibia
Total
Density
Cortical
Thickness
Total
Density
Cortical
Thickness
Thbs2 1/1 450.5 6 25 0.26 6 0.016 480.8 6 34.3 0.238 6 0.031
Thbs2 2/2 498.5 6 24 0.29 6 0.017 538.1 6 31.6 0.275 6 0.013
P < 0.05 P < 0.05 P < 0.05 P < 0.05
The total bone density of the femur and tibia (expressed as mg/cm3) was determined
by quantitative computerized tomography of the bone at mid-diaphysis. Cortical bone
thickness, (in mm) at mid-diaphysis, was calculated from computer-generated algo-
rithms based on cross-sectional geometries. Values represent mean 6 SEM; n 5 5 for
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neonatal, and embryonic dermis, adult and embryonic
subcutaneous adipose tissue, and embryonic thymus were
immunostained with an antibody to vWF, and endothelial
cell–containing vascular structures were counted by an in-
vestigator who had no knowledge of the genotype of the
tissue. The results are summarized in Table II. On aver-
age, there were twice as many blood vessels in a 403 mi-
croscopic field (0.075 mm2) in sections from adult mutant
mice, compared with those from control animals, and all
comparisons were different with a high degree of statisti-
cal significance. Interestingly, the differences for neonatal
and embryonic dermis were not as great as those for the
adult tissue. Representative sections of neonatal dermis
from Thbs2 1/1 and Thbs2 2/2 mice, stained for vWF,
are shown in Fig. 11.
Discussion
The Phenotype of the TSP2-null Mouse
The TSP2-null mouse is normal in size and appearance
and reproduces normally. To the trained investigator, how-
ever, these mice are distinctive. Juvenile mice often have
subtle bends in their tails that tend to become less distinct
as they mature. The skin of adult mice feels more stretch-
able and the tail is clearly more flexible, as evidenced by
the ability to fashion knots in it (Fig. 2). These overt indi-
cations of abnormalities in connective tissue structure and
function are supported by anatomical analysis and me-
chanical testing. The weave of dermal collagen fibers in
the TSP2 knockout mouse is disorganized (Fig. 3 B), and
collagen fibrils in skin and tendon are abnormally large
and irregularly contoured when examined by electron mi-
croscopy (Figs. 5, 6, and 8). Tensile strength measure-
ments of skin from mutant animals support indications of
increased fragility, first suggested by the tendency of skin
to tear. Skin from TSP2-null mice ruptures at lower loads
and has increased ductility (Fig. 7); these findings explain
its increased stretchability. A possible clue to the patho-
genesis of these disorders lies in the abnormalities of at-
tachment documented in skin fibroblasts from mutant
animals (Figs. 9 and 10). TSP2-null mice also show an in-
crease in cortical bone width (Fig. 3, C and D). Finally,
mutant mice have a significant increase in density in small
blood vessels in skin and other tissues, and an abnormally
long bleeding time.
It should be emphasized that there was considerable
variability in the extent to which these various abnormali-
ties were expressed in individual Thbs2 2/2 mice. This
variability probably reflects, in part, the mixed genetic
background (129/SvJ and C57BL/6) of the mice. It is now
well established that genetic background can have a signif-
icant impact on the expression of a knockout phenotype
(see Bonyadi et al., 1997 as a recent example relating to
TGFb1 knockout mice). We have transferred the TSP2 mu-
tation to a pure 129 background, and have confirmed the
major features of the phenotype, but have not yet deter-
mined whether the variability in the phenotype is reduced.
What Is the Basis for the Disordered Collagen Fibrils in 
TSP2-null Mice?
In vitro, homotypic collagen fibril formation is an entropy-
driven, self-assembly process (Kadler et al., 1996). How-
ever, the situation in vivo is more complex. The presence
of fibril-associated collagens and other macromolecules
together with type I collagen in heterotypic fibrils affects
properties such as form and diameter (Birk and Linsen-
mayer, 1994). Thus, Marchand et al. (1996) have used a
dominant-negative strategy, involving the retroviral trans-
duction of corneal fibroblasts with a truncated a1(V) mini-
gene, to show by inference that the presence of type V col-
lagen reduces the diameter of type I collagen fibrils. A
requirement for type V collagen in collagen fibrillogenesis
was shown definitively in mice by targeting a mutation to
the Col5A2 gene. Homozygous a2(V) mutant mice dem-
onstrated a severe skin fragility, and corneal collagen fibrils
Table II. Quantification of Blood Vessels in Tissue Sections
Tissue
Blood vessels per 403 field*
Thbs2 1/1 Thbs2 2/2
Adult adipose 7.4 6 1.2‡ 17.3 6 2.3
Embryonic adipose 9.7 6 3.1 17.2 6 5.6
Adult dermis 5.1 6 2.0 10.0 6 2.4
Neonatal dermis 8.9 6 2.8 12.9 6 2.8
Embryonic dermis 18.8 6 2.2 22.5 6 3.5
Embryonic thymus 13.1 6 1.5 22.9 6 2.4
*Sections were imunostained with an antibody to vWF. Counts are the averages of 7–20
403 microscopic fields (0.075 mm2/field) obtained by examination of 6 mm sections
from four control and three mutant mice.
‡Standard deviation. All differences between sections from TSP2 1/1 and TSP2 2/2
mice are significant at a level of P < 0.001, with the exception of embryonic dermis
for which the level of significance is P < 0.04.
Figure 11. Immunohistochemical analysis for vWF of back skin
from (A) a Thbs2 1/1 mouse and (B) a Thbs2 2/2 mouse. The
sections were counterstained with hematoxylin. These sections
are representative of those reported in Table II and show the in-
creased vascular density in TSP2-null mice. Bar, 50 mm.The Journal of Cell Biology, Volume 140, 1998 428
were reported to be wider than normal (Andrikopoulos
et al., 1995). Similarly, the decorin knockout mouse was
recently reported (Danielson et al., 1997) to have fragile
skin with larger, irregularly contoured collagen fibrils that
resemble, in some respects, the fibrils seen in the TSP2
knockout mouse. We have examined the skin of Thbs2 2/2
and control mice by histochemical analysis with antideco-
rin antibodies (a gift of L. Fisher, National Institute of
Dental Research, National Institutes of Health, Bethesda,
MD) and found no difference in the level of staining (our
unpublished results).
The presence of skin fragility and abnormal collagen
fibrils in the TSP2 and decorin knockout mice, and in the
a2(V) mutant mouse, raise the possibility that, like type V
collagen and decorin, TSP2 might function as a collagen
fibril-associated protein that regulates fibril diameter and
fibrillogenesis. Although, to our knowledge, the binding of
TSP2 to collagens has not been studied, TSP1 has been
shown to bind to a number of collagens including types I
and V (Mumby et al., 1984; Galvin et al., 1987). Binding
was dependent on the native conformation of the collagen
and involved a chymotrypsin-resistant fragment of TSP1
(Mumby et al., 1984), that is now known to include the
procollagen homology domain and type I repeats (Galvin
et al., 1987). Because of similarities of amino acid sequence
between TSP1 and TSP2 in these regions of the proteins
(Bornstein, 1992; Laherty et al., 1992), it is likely that
TSP2 will also be found to bind types I and V collagens,
but whether TSP2 functions as a fibril-associated protein is
not known. Immunohistochemical analysis of skin with anti-
TSP2 antibodies (Fig. 4) suggests the presence of some
staining in control tissue that is not obviously within cells,
but whether or not this reaction product represents TSP2
that is specifically associated with collagen fibrils will re-
quire examination at the ultrastructural level.
It has been suggested that fibroblasts compartmentalize
the adjacent extracellular space to enable fibrils to assem-
ble in deep crevasses or channels, largely surrounded by
the cell surface (Birk and Trelstad, 1986; Ploetz et al.,
1991; Birk and Linsenmayer, 1994). The process of fibril
growth is presumed to occur by retraction of cell processes
and lateral aggregation of fibrils. In view of the defect that
we have identified in the attachment properties of skin fi-
broblasts from TSP2-null mice (Figs. 9 and 10) it seems
possible that an alternative or additional explanation for
the disordered collagen fibrillogenesis in these mice re-
flects the altered cell surface properties of fibroblastic cells,
and their inability to interact normally with collagen fibrils.
Skin Fibroblasts from TSP2-null Mice Display a Defect 
in Attachment to a Substratum
In vitro, fibroblasts are capable of interacting, by means of
integrins and nonintegrin cell surface receptors, to a vari-
ety of extracellular matrix proteins, including fibronectin,
collagens, and laminins, and to matricellular proteins such
as TSP1 and TSP2, tenascins, and secreted protein acidic,
and rich in cysteine (SPARC). In some studies, attach-
ment of human embryonic fibroblasts to TSP1 was shown
to lead rapidly to spreading and to the formation of focal
adhesions that were mediated by a number of receptors,
including avb3 integrin and CD36 (Stomski et al., 1992).
However, in the case of endothelial cells, smooth muscle
cells, and myoblasts, TSP1, and probably TSP2, inhibit the
formation of focal contacts, and these proteins are also ca-
pable of destabilizing focal adhesions formed by adhesive
proteins such as fibronectin (Murphy-Ullrich and Höök,
1989; Murphy-Ullrich et al., 1993; Sipes et al., 1993; Ad-
ams, 1995; Murphy-Ullrich et al., 1996). We have found
that skin fibroblasts from TSP2-null mice attach more
poorly to tissue culture plastic than do control fibroblasts,
and that this defect cannot be corrected by plating the cells
on a number of matrix proteins, including TSP2. In prelim-
inary studies we have also found that TSP2-null cells do
not contract a collagen gel normally (our unpublished re-
sults). These findings suggest that TSP2 functions as a
proadhesive protein for fibroblasts, but that the basis for
the attachment defect in cells lacking TSP2 is not simply
the absence of a suitable substratum.
How Might a Lack of TSP2 Cause an Increase in
Bone Density?
An increase in bone density in mice and humans most
commonly results from reduced resorption of bone by os-
teoclasts, a condition which is termed osteopetrosis (Pop-
off and Marks, 1995). In mice, osteoclast function can be
compromised either metabolically, e.g., by targeted dis-
ruption of the gene encoding tartrate-resistant acid phos-
phatase (Hayman et al., 1996), or by a block in differentia-
tion of osteoclast precursor cells. Not all increases in bone
density involve osteoclasts, as the bone defect in the osteo-
calcin-deficient mouse results from an increase in bone
formation rather than from an impairment in bone resorp-
tion (Ducy et al., 1996). Histomorphometric studies are
currently in progress to determine whether changes in
bone formation or resorption are operative in TSP2-null
mice. If the latter mechanism is implicated, the bone de-
fect in TSP2-null mice could result from a defect in osteo-
clast adhesion to bone, or from a failure to form a bone-
resorbing ruffled border. The origin of this putative defect
may have parallels with the attachment defect that we have
begun to investigate in skin fibroblasts. Alternatively, the
differentiation of osteoclast precursors in the marrow
could be affected by abnormalities in the stromal matrix or
in stromal-precursor cell interactions.
The Bleeding Diathesis and Vascular Abnormality in 
TSP2-null Mice
Although platelet a granules contain abundant TSP1
(McGregor and Boukerche, 1993), there is no evidence for
the presence of TSP2 in platelets. Indeed, Thbs1 mRNA,
but not Thbs2 mRNA, is readily detected by in situ hybrid-
ization in hematopoietic precursor cells in developing
mouse embryo liver, spleen, and bone marrow (Iruela-
Arispe et al., 1993). Similarly, TSP1 but not TSP2, can be
detected by Western analysis of adult mouse serum (our
unpublished observations). Provided platelet function can
be shown to be normal, the most probable cause of the
bleeding diathesis in TSP2-null mice is defective adhesion
of platelet aggregates to the injured subendothelium. The
role of vWF in anchoring aggregated platelets to the sub-
endothelium is well established, and mutations in the vWF
gene are a common cause of bleeding disorders in humansKyriakides et al. Thrombospondin 2 Knockout Mice 429
(Sadler, 1995), but the nature of the interaction between
vWF and the subendothelium is still not well understood
(Sixma and deGroot, 1994; Weiss, 1995). There is evidence
that collagen types I, III, IV, and VI and fibronectin may
be involved in mediating platelet adhesion (Houdijk et al.,
1986; Weiss, 1995). TSP1 has been shown to bind to vWF
(Mumby et al., 1984; Barabino et al., 1997), and it is not
unreasonable to suggest that this will also be true for
TSP2. In view of the derangement of collagen fibrillogene-
sis in TSP2-null mice, it seems possible that TSP2 is re-
quired, either directly or indirectly, for the binding of vWF
to one or more collagens in the subendothelium.
The increase in blood vessel density in TSP2-null mice is
indubitable (Table II), and this finding provides, we be-
lieve, the strongest argument yet presented for the func-
tion of a thrombospondin as an inhibitor of angiogenesis
in vivo. TSP2 has been shown to inhibit the migration of
bovine adrenal capillary endothelial cells in a modified Boy-
den chamber, and to inhibit basic FGF-induced neovascu-
larization in the rat cornea (Volpert et al., 1995). With the
exception of this study, all previously published work on
the role of TSPs in angiogenesis has involved TSP1 and
this work has generated considerable controversy (for
reviews see Roberts, 1996; Tuszynski and Nicosia, 1996;
Bouck, 1996; and Bouck et al., 1996). Based on a reading
of the literature, one reaches the conclusion that whereas
TSP1 can be considered to be antiangiogenic in assays in-
volving endothelial migration or corneal neovasculariza-
tion, the situation in vivo might be more complex. A reso-
lution of conflicting findings may lie in recognition of the
diversity of function inherent in matricellular proteins such
as TSP1 (Bornstein, 1995). In addition to its intrinsic abil-
ity to modulate angiogenesis by variably affecting the ad-
hesion, migration, and proliferation of endothelial cells
(see reviews above), TSP1 can bind basic FGF (Tarabo-
letti et al., 1997), which could either present or sequester
this potent proangiogenic growth factor. TSP1 could also
recruit cells whose net effect would be proangiogenic, as
postulated by Nicosia and Tuszynski (1994) in their rat
aortic ring culture model. Although the detailed pheno-
type of the TSP1 knockout mouse has not been published,
Stellmach et al. (1996) reported that TSP1-null mice have
an increase in blood vessels in the anterior and posterior
chambers of the eye, but presumably not a generalized in-
crease in vascular density. Because these tissue compart-
ments are relatively isolated from invasion by cells in adja-
cent tissues, it is possible that the absence of TSP1 could
tilt the balance of pro- and antiangiogenic factors in favor
of the former. On the other hand, the activities of TSP2
may be more purely antiangiogenic if, for example, the
protein is less capable of recruiting cells from adjacent sites,
which could contribute an angiogenic effect. As a result,
the lack of TSP2 would lead to the more generalized in-
crease in vascular density that we have observed in the
TSP2 knockout mouse.
Conclusions
The phenotype of the TSP2-null mouse implicates TSP2 in
collagen fibrillogenesis, bone growth, maintenance of a
normal vascular density, hemostasis, and in the attach-
ment properties of skin fibroblasts and perhaps other cells.
With the possible exception of the vascular effect, none of
these findings could have been predicted from the known
functions of TSP1 or TSP2. This study, therefore, makes a
strong argument for the use of gene targeting as a means
of assessing biological function, although there are cer-
tainly many instances in which overlapping functions or
gene compensation can obscure the function of a missing
protein (Bornstein, 1995; Hynes, 1996). The striking defect
in collagen fibrils in skin and tendon of TSP2-null mice
suggests that TSP2 may function as a fibril-associated struc-
tural component in these tissues. However, an equally plau-
sible explanation can be provided by postulating a defect
in cell surface properties of fibroblasts. Although, at first
glance, the finding of an attachment defect in fibroblasts
from TSP2-null mice would appear to contradict the re-
port that the protein functions to reduce focal adhesions in
endothelial and smooth muscle cells (Murphy-Ullrich et al.,
1993), this conclusion is not necessarily justified. TSP2,
through its interaction with multiple cell surface receptors
and the consequent generation of intracellular signals, may
be responsible for a variety of cell surface properties, the
loss of which characterize the TSP2-null fibroblast. There-
fore, a comparison cannot be readily made between the be-
havior of a cell that is deficient in an extracellular protein
and that of a normal cell to which an excess of that protein
is added. For a similar reason, one would not expect the
addition of TSP2 to TSP2-null fibroblasts to correct func-
tional defects in short term experiments. We believe that
the TSP2-null mouse and its cells represent a unique and
valuable resource for studies of matrix synthesis and as-
sembly, angiogenesis, bone growth, and hemostasis.
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